CC BY-NC-ND 4.0 · Avicenna J Med 2022; 12(04): 182-185
DOI: 10.1055/s-0042-1756675
Case Report

Aldosterone-Secreting Large Oncocytic Neoplasm of the Adrenal Gland with Borderline Potential

Maher Alshaheen
1   Department of Internal Medicine, Bahrain Specialist Hospital, Manama, Kingdom of Bahrain
,
Krishanu Das
2   Department of Urology and Andrology, Bahrain Specialist Hospital. Manama, Kingdom of Bahrain
,
Mary Jean
3   Department of Pathology, Bahrain Specialist Hospital, Manama, Kingdom of Bahrain
,
4   Department for Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany
› Institutsangaben
Funding None.

Abstract

Adrenal oncocytomas are rare tumors that are mostly benign and non-functional although they may be hormonally active and can exhibit a borderline or malignant potential. We present a case of a 40-year-old female patient with known hypertension who presented with abdominal discomfort. Radiologic investigations showed a large mass on the left adrenal gland. In the hormonal study, an aldosterone-secreting tumor was identified. After laparoscopic resection, the histological assessment of the 12-cm mass showed an oncocytic neoplasm with borderline characteristics. The laboratory results returned to normal and the hypertensive disease improved. The patient was doing well after 14 months of follow-up. This is the seventh documented case of aldosterone-secreting oncocytoma, the first borderline tumor of this type, and the largest reported tumor so far.

Patient Consent

Written informed consent was obtained from the patient and is available on request.


Authors' Contributions

K.D. operated on the patient and wrote the first draft. M.A. was involved in the diagnostic work-up and follow-up, collected the clinical data, and edited the manuscript. M.J. examined the specimen and contributed to the pathologic details of the work. M.F.S. researched the documented cases, organized the figures and tables, and edited the discussion. All authors reviewed and approved the final manuscript before submission.




Publikationsverlauf

Artikel online veröffentlicht:
15. September 2022

© 2022. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Duregon E, Volante M, Cappia S. et al. Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases. Am J Surg Pathol 2011; 35 (12) 1882-1893
  • 2 Wong DD, Spagnolo DV, Bisceglia M, Havlat M, McCallum D, Platten MA. Oncocytic adrenocortical neoplasms–a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Hum Pathol 2011; 42 (04) 489-499
  • 3 Bisceglia M, Ludovico O, Di Mattia A. et al. Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 2004; 12 (03) 231-243
  • 4 Beuschlein F, Weigel J, Saeger W. et al. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 2015; 100 (03) 841-849
  • 5 Panizzo V, Rubino B, Piozzi GN. et al. Laparoscopic trans-abdominal right adrenalectomy for a large primitive adrenal oncocytic carcinoma: a case report and review of literature. Am J Case Rep 2018; 19: 1096-1102
  • 6 Ali AE, Raphael SJ. Functional oncocytic adrenocortical carcinoma. Endocr Pathol 2007; 18 (03) 187-189
  • 7 Mete O, Asa SL. Aldosterone-producing adrenal cortical adenoma with oncocytic change and cytoplasmic eosinophilic globular inclusions. Endocr Pathol 2009; 20 (03) 182-185
  • 8 Stowasser M, Gordon RD, Gunasekera TG. et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients. J Hypertens 2003; 21 (11) 2149-2157
  • 9 Li X, Goswami R, Yang S, Li Q. Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2016; 17 (03) 1470320316657450
  • 10 Akin M, Erginel B, Tanik C. et al. The first laparoscopic resection of an aldosterone-secreting adrenocortical oncocytoma in a child. J Pediatr Surg Case Rep 2014; 2 (09) 424-427